106 related articles for article (PubMed ID: 666183)
1. Nephrotoxicity from cancer immunotherapy.
Dosik GM; Gutterman JU; Hersh EM; Akhtar M; Sonoda T; Horn RG
Ann Intern Med; 1978 Jul; 89(1):41-6. PubMed ID: 666183
[TBL] [Abstract][Full Text] [Related]
2. Proliferative glomerulonephritis in mice given intravenous Corynebacterium parvum.
Uff JS; Mitcheson HD; Pussell BA; Brill M; Castro JE
J Pathol; 1981 Feb; 133(2):89-105. PubMed ID: 6451676
[TBL] [Abstract][Full Text] [Related]
3. Corynebacterium parvum versus bacille Calmette-Guérin adjuvant immunotherapy of stage II malignant melanoma.
Lipton A; Harvey HA; Balch CM; Antle CE; Heckard R; Bartolucci AA
J Clin Oncol; 1991 Jul; 9(7):1151-6. PubMed ID: 2045856
[TBL] [Abstract][Full Text] [Related]
4. The effect of Corynebacterium parvum therapy on immunoglobulin class and IgG subclass levels in cancer patients.
James K; Clunie GJ; Woodruff MF; McBride WH; Stimson WH; Drew R; Catty D
Br J Cancer; 1975 Sep; 32(3):310-22. PubMed ID: 61040
[TBL] [Abstract][Full Text] [Related]
5. Immune-complex glomerulonephritis secondary to nonspecific immunotherapy.
Krutchik AN; Buzdar AU; Akhtar M; Blumenschein GR
Cancer; 1980 Feb; 45(3):495-7. PubMed ID: 6444365
[TBL] [Abstract][Full Text] [Related]
6. Chemoimmunotherapy (DTIC and Corynebacterium parvum) as adjuvant treatment in malignant melanoma.
Karakousis CP; Didolkar MS; Lopez R; Baffi R; Moore R; Holyoke ED
Cancer Treat Rep; 1979; 63(11-12):1739-43. PubMed ID: 393377
[TBL] [Abstract][Full Text] [Related]
7. A trial of imidazole carboxamide and corynebacterium parvum in disseminated melanoma: clinical and immunologic results.
Clunie GJ; Gough IR; Dury M; Furnival CM; Bolton PM
Cancer; 1980 Aug; 46(3):475-9. PubMed ID: 6994866
[TBL] [Abstract][Full Text] [Related]
8. DTIC and actinomycin D with and without C. parvum immunotherapy in advanced malignant melanoma.
Halpern J; Catane R; Biran S; Fuks Z
Tumori; 1981; 67(3):215-7. PubMed ID: 7281240
[No Abstract] [Full Text] [Related]
9. Effects of BCG and Corynebacterium parvum on immune reactivity in melanoma patients.
Thatcher N; Crowther D
Dev Biol Stand; 1977 Apr 13-15; 38():449-53. PubMed ID: 608536
[TBL] [Abstract][Full Text] [Related]
10. Membranoproliferative glomerulonephritis. Localization of early components of complement in glomerular deposits.
Davis BK; Cavallo T
Am J Pathol; 1976 Aug; 84(2):283-98. PubMed ID: 133617
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis-B-associated glomerulonephritis: pathology, pathogenesis, and clinical course.
Venkataseshan VS; Lieberman K; Kim DU; Thung SN; Dikman S; D'Agati V; Susin M; Valderrama E; Gauthier B; Prakash A
Medicine (Baltimore); 1990 Jul; 69(4):200-16. PubMed ID: 2142748
[TBL] [Abstract][Full Text] [Related]
12. Proliferative glomerulonephritis and chronic active hepatitis with cirrhosis associated with Corynebacterium parvum immunotherapy in a dog.
Leifer CE; Page RL; Matus RE; Patnaik AK; MacEwen EG
J Am Vet Med Assoc; 1987 Jan; 190(1):78-80. PubMed ID: 3818425
[No Abstract] [Full Text] [Related]
13. Surgical adjuvant therapy of malignant melanoma with corynebacterium parvum.
Hilal EY; Pinsky CM; Hirshaut Y; Wanebo HJ; Hansen JA; Braun DW; Fortner JG; Oettgen HF
Cancer; 1981 Jul; 48(2):245-51. PubMed ID: 7016302
[TBL] [Abstract][Full Text] [Related]
14. Complement activation in vivo in cancer patients receiving C. parvum immunotherapy.
Biran H; Moake JL; Reed RC; Gutterman JU; Hersh EM; Freireich EJ; Mavligit GM
Br J Cancer; 1976 Nov; 34(5):493-9. PubMed ID: 999783
[TBL] [Abstract][Full Text] [Related]
15. Inefficacy of sc Corynebacterium parvum in stage I malignant melanoma: preliminary results of a single-institution pilot study.
Murray JL; Ishmael DR; Bottomley RH; Grozea PN; Lee ET
Cancer Treat Rep; 1983 Feb; 67(2):191-2. PubMed ID: 6825130
[No Abstract] [Full Text] [Related]
16. Diffuse proliferative lupus glomerulonephritis. Determination of prognostic significance of clinical, laboratory and pathologic factors.
Magil AB; Ballon HS; Chan V; Lirenman DS; Rae A; Sutton RA
Medicine (Baltimore); 1984 Jul; 63(4):210-20. PubMed ID: 6377004
[TBL] [Abstract][Full Text] [Related]
17. Malignant melanoma with renal dense deposits containing tumor antigens.
Olson JL; Philips TM; Lewis MG; Solez K
Clin Nephrol; 1979 Aug; 12(2):74-82. PubMed ID: 393445
[TBL] [Abstract][Full Text] [Related]
18. Treponemal antigen in immunopathogenesis of syphilitic glomerulonephritis.
Tourville DR; Byrd LH; Kim DU; Zajd D; Lee I; Reichman LB; Baskin S
Am J Pathol; 1976 Mar; 82(3):479-92. PubMed ID: 130804
[TBL] [Abstract][Full Text] [Related]
19. Henoch-Schoenlein syndrome: a clinical and morphological study of renal biopsies.
Sinniah R; Feng PH; Chen BT
Clin Nephrol; 1978 Jun; 9(6):219-28. PubMed ID: 668222
[TBL] [Abstract][Full Text] [Related]
20. Hypercoagulability after immunotherapy with Corynebacterium parvum in man.
Harenberg J; Baumgärtner A; Fritze D; Zimmermann R
Blut; 1982 Apr; 44(4):241-7. PubMed ID: 7082858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
